GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Know Labs Inc (AMEX:KNW) » Definitions » Cash Flow from Financing

Know Labs (Know Labs) Cash Flow from Financing : $6.05 Mil (TTM As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Know Labs Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2023, Know Labs received $0.20 Mil more from issuing new shares than it paid to buy back shares. It received $0.00 Mil from issuing more debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.00 Mil on other financial activities. In all, Know Labs earned $0.20 Mil on financial activities for the three months ended in Dec. 2023.


Know Labs Cash Flow from Financing Historical Data

The historical data trend for Know Labs's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Know Labs Cash Flow from Financing Chart

Know Labs Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.15 6.38 15.11 8.11 5.87

Know Labs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 - 0.38 5.47 0.20

Know Labs Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Know Labs's Cash from Financing for the fiscal year that ended in Sep. 2023 is calculated as:

Know Labs's Cash from Financing for the quarter that ended in Dec. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Know Labs  (AMEX:KNW) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Know Labs's issuance of stock for the three months ended in Dec. 2023 was $0.20 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Know Labs's repurchase of stock for the three months ended in Dec. 2023 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Know Labs's net issuance of debt for the three months ended in Dec. 2023 was $0.00 Mil. Know Labs received $0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Know Labs's net issuance of preferred for the three months ended in Dec. 2023 was $0.00 Mil. Know Labs paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Know Labs's cash flow for dividends for the three months ended in Dec. 2023 was $0.00 Mil. Know Labs received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Know Labs's other financing for the three months ended in Dec. 2023 was $0.00 Mil. Know Labs received $0.00 Mil on other financial activities.


Know Labs Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Know Labs's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Know Labs (Know Labs) Business Description

Industry
Traded in Other Exchanges
N/A
Address
500 Union Street, Suite 810, Seattle, WA, USA, 98101
Know Labs Inc is a medical diagnostic. The company is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or microneedles.
Executives
Todd Baszucki 10 percent owner 519 LOMA ALTA ROAD, CARMEL CA 93923
Jessica English officer: Chief Marketing Officer 34 GRANADA DRIVE, CORTE MADERA CA 94925
Leonardo Mouta Trautwein officer: Chief Marketing Officer PO BOX 2021, PARK CITY UT 84060
Takesako Ichiro John Paul director 500 UNION STREET, SUITE 420, SEATTLE WA 98101
Peter J Conley officer: Chief Financial Officer 3658 PRICE HILLS DRIVE, SAINT GEORGE UT 84790
Steven T Kent officer: Chief Product Officer 185 CHANNEL ST, APT 545, SAN FRANCISCO CA 94158
William Arthur Owens director C/O CENTURYLINK, INC., 100 CENTURYLINK DRIVE, MONROE LA 71203
Ronald P Erickson director, officer: Chairman 9437 NE CORAL COURT, BAINBRIDGE ISLAND WA 98110
Jon Pepper director 500 UNION STREET, SUITE 810, SEATTLE WA 98101
Phillip Bosua director, 10 percent owner, officer: CEO and President 500 UNION STREET, SUITE 810, SEATTLE WA 98101
Jeff T Wilson officer: CFO
Jeffrey Richard Kruse other: Pres. of TransTech Systems Inc 12142 NE SKY LANE, SUITE 130, AURORA OR 97002
Todd Martin Sames officer: V.P. of Business Development 500 UNION STREET, SUITE 420, SEATTLE WA 98101
Richard Mander officer: VP Product Mgmnt & Technology 500 UNION STREET, STE 406, SEATTLE WA 98101
Bonderson Paul R Jr director

Know Labs (Know Labs) Headlines

From GuruFocus

Know Labs, Inc. to Present at the LD 500 Virtual Conference

By ACCESSWIRE ACCESSWIRE 08-25-2020